Ophthalmic pharmaceutical compositions and uses thereof

TW202639116APending Publication Date: 2026-10-01ALCON INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115100534
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-25
Filing Date
2026-01-07
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078953_001
    Figure TWG2TA001078953_001
  • Figure TWG2TA001078953_002
    Figure TWG2TA001078953_002
  • Figure TWG2TA001078953_003
    Figure TWG2TA001078953_003
Patent Text Reader

Abstract

The present invention provides a topical ophthalmic pharmaceutical composition of (1R,2S,5R)-2-isopropyl-N-(4-methoxyphenyl)-5-methylcyclohexane-1-methamide (WS-12, acoltremon) in an LDPE container, a method for manufacturing the composition, and its use in ophthalmic therapeutic agents. Provided herein are topical ophthalmic pharmaceutical compositions of (1R,2S,5R)-2-isopropyl-N-(4-methoxyphenyl)-5-methylcyclohexane-1-carboxamide (WS-12, acoltremon) in LDPE containers, their methods of manufacture, and uses thereof in ocular therapeutics.
Need to check novelty before this filing date? Find Prior Art